Showing results (551-560 of 995) with videos related to
Sort By:
Pageof 100
Cell and Tissue Research|October 27, 2010
Effect of 6-hydroxydopamine (6-OHDA) on proliferation of glial cells in the rat cortex and striatum: evidence for de-differentiation of resident astrocytesBritta Wachter, Sonja Schürger, Jens Rolinger, et al.Journal of Neurology|November 5, 2015
Autonomic dysfunction in subjects at high risk for Parkinson's diseaseInga Liepelt-Scarfone, Andrea Pilotto, Katharina Müller, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 16, 2013
SNCA: major genetic modifier of age at onset of Parkinson's diseaseKathrin Brockmann, Claudia Schulte, Ann-Kathrin Hauser, et al.Neurobiology of Aging|May 26, 2009
No evidence of association of FLJ10986 and ITPR2 with ALS in a large German cohortRubén Fernández-Santiago, Manu Sharma, Daniela Berg, et al.Journal of Parkinson'S Disease|August 28, 2019
Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian DisordersMorinobu Seki, Klaus Seppi, Christoph Mueller, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 31, 2007
Depression rating scales in Parkinson's disease: critique and recommendationsAnette Schrag, Paolo Barone, Richard G Brown, et al.Neurology|January 23, 2015
Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBDPhilipp Mahlknecht, Alex Iranzo, Birgit Högl, et al.Movement Disorders Clinical Practice|October 9, 2020
Has Deep Brain Stimulation Changed the Very Long-Term Outcome of Parkinson's Disease? A Controlled Longitudinal StudyPhilipp Mahlknecht, Marina Peball, Katherina Mair, et al.The Lancet. Neurology|April 13, 2011
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomesOlivier Rascol, Cheryl J Fitzer-Attas, Robert Hauser, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 27, 2016
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approachJohannes Levin, Sylvia Maaß, Madeleine Schuberth, et al.Pageof 100